Drug class
Anthracene derivative; topical antipsoriatic agent
Mechanism of action
Inhibits keratinocyte proliferation and alters epidermal differentiation. It also generates reactive oxygen species in skin, contributing to local anti-inflammatory and antiproliferative effects.
General use cases
- Topical treatment of chronic plaque psoriasis, often as short-contact therapy or under specialist dermatological supervision; concentration and contact time are product-specific
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
